Roche is narrowing its pipeline to 11 disease areas and continuing to invest in a targeted way, said Teresa Graham, chief ...

Severin Schwan criticized the subsidies that the U.S. and European governments are using to boost their manufacturing ...

Tolerability issues for CT-388 and CT-996 may impact Roche Holdings AG, but strong pipeline prospects remain. Discover why ...

Roche narrows pipeline to focus more on weight-loss franchise, following setbacks in Alzheimer's and lung cancer ...

Maybe you should dial back your training for better performance.

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable ...

Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes ...

Swiss drug major Roche Group (RHHBY) announced Tuesday the launch of the cobas Respiratory flex test, the first to use Roche's novel ...

The TAGS technology has PCR testing capabilities on high-throughput systems such as the cobas 5800, 6800, and 8800 models.

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its ...

Roche Holdings AG (OTC:RHHBY) released positive topline results of the phase 3 CENTERSTONE study of Xofluza (baloxavir ...